Inventor
SAUERBERG PER
DK101 patents
⚠️ This page may combine multiple inventors who share the name “SAUERBERG PER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
34 patentsUS5043345AAug 27, 1991
Piperidine compounds and their preparation and use
NOVO NORDISK AS111 citations97
US5041455AAug 20, 1991
Piperidine compounds and their preparation and use
NOVO NORDISK AS101 citations97
US5260314ANov 9, 1993
Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
NOVO NORDISK AS59 citations96
US10278923B2May 7, 2019
Oral dosing of GLP-1 compounds
NOVO NORDISK AS29 citations93
US10086047B2Oct 2, 2018
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
NOVO NORDISK AS26 citations93
US6602901B2Aug 5, 2003
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
NOVO NORDISK AS14 citations93
US6468996B1Oct 22, 2002
Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
NOVO NORDISK AS33 citations93
US6248781B1Jun 19, 2001
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
NOVO NORDISK AS26 citations93
US5328923AJul 12, 1994
Heterocyclic compounds and use
NOVO NORDISK AS27 citations93
US5328924AJul 12, 1994
Heterocyclic compounds and their use
NOVO NORDISK AS30 citations93
US11382957B2Jul 12, 2022
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
NOVO NORDISK AS11 citations92
US10960052B2Mar 30, 2021
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
NOVO NORDISK AS19 citations92
US7202213B2Apr 10, 2007
Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
NOVO NORDISK AS21 citations92
US7091245B2Aug 15, 2006
Compounds, their preparation and use
NOVO NORDISK AS22 citations92
US7067530B2Jun 27, 2006
Compounds, their preparation and use
NOVO NORDISK AS22 citations92
US6869967B2Mar 22, 2005
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
NOVO NORDISK AS26 citations92
US6569901B2May 27, 2003
Alkynyl-substituted propionic acid derivatives, their preparation and use
NOVO NORDISK AS33 citations92
US6555577B1Apr 29, 2003
Compounds, their preparation and use
NOVO NORDISK AS28 citations92
US6274608B1Aug 14, 2001
Compounds, their preparation and use
NOVO NORDISK AS23 citations92
US9993430B2Jun 12, 2018
Tablet formulation comprising semaglutide and a delivery agent
NOVO NORDISK AS18 citations90
US5262427ANov 16, 1993
3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions
NOVO NORDISK AS21 citations89
US7220877B2May 22, 2007
Compounds, their preparation and use
NOVO NORDISK AS12 citations84
US7129268B2Oct 31, 2006
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
NOVO NORDISK AS20 citations84
US6972294B1Dec 6, 2005
Compounds, their preparation and use
NOVO NORDISK AS18 citations84
US6867218B2Mar 15, 2005
Compounds, their preparation and use
NOVO NORDISK AS17 citations84
US6214820B1Apr 10, 2001
Compounds, their preparation and use
NOVO NORDISK AS15 citations84
US9498534B2Nov 22, 2016
Derivatives of GLP-1 like peptides, and uses thereof
NOVO NORDISK AS13 citations83
US5578602ANov 26, 1996
Certain 1-azabicyclo[3.3.1]nonene derivatives and their pharmacological uses
NOVO NORDISK AS17 citations82
US5571826ANov 5, 1996
Heterocyclic compounds and their preparation and use
NOVO NORDISK AS14 citations82
US5527813AJun 18, 1996
Heterocyclic compounds and their preparation and use
NOVO NORDISK AS17 citations82
US11033499B2Jun 15, 2021
Tablet formulation comprising a GLP-1 peptide and a delivery agent
NOVO NORDISK AS8 citations80
US5356912AOct 18, 1994
3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease
NOVO NORDISK AS17 citations79
US12239739B2Mar 4, 2025
Oral dosing of GLP-1 compounds
NOVO NORDISK AS2 citations74
US6353018B1Mar 5, 2002
Compounds, their preparation and use
NOVO NORDISK AS9 citations74
HIGH POINT PHARMACEUTICALS LLC
5 patentsUS8551993B2Oct 8, 2013
Phenoxy acetic acids as PPAR delta activators
HIGH POINT PHARMACEUTICALS LLC13 citations92
US8362016B2Jan 29, 2013
Phenyl propionic acids as PPAR delta activators
HIGH POINT PHARMACEUTICALS LLC15 citations92
US7943613B2May 17, 2011
Compounds, their preparation and use
HIGH POINT PHARMACEUTICALS LLC22 citations92
US7816385B2Oct 19, 2010
Dimeric dicarboxylic acid derivatives, their preparation and use
HIGH POINT PHARMACEUTICALS LLC9 citations84
US7709528B2May 4, 2010
Compounds, their preparation and use
HIGH POINT PHARMACEUTICALS LLC15 citations84
VTV THERAPEUTICS LLC
4 patentsUS10471066B2Nov 12, 2019
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC6 citations84
US9855274B2Jan 2, 2018
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC7 citations84
US9663481B2May 30, 2017
Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists
VTV THERAPEUTICS LLC7 citations84
US10947180B2Mar 16, 2021
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC4 citations81
FERROSAN AS
2 patentsUS4837241AJun 6, 1989
Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions
FERROSAN AS41 citations95
US4933353AJun 12, 1990
Lipophilically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions (II)
FERROSAN AS23 citations92
SAUERBERG PER
1 patentGARIBAY PATRICK WILLIAM
1 patentNOVO NORDISK ALS
1 patentMADSEN ALICE RAVN
1 patentLILLY CO ELI
1 patentShowing the top 50 of 101 patents by PatentIndex Score.